CN103768150A - Traditional Chinese medicine effective part composition for treating cataract - Google Patents

Traditional Chinese medicine effective part composition for treating cataract Download PDF

Info

Publication number
CN103768150A
CN103768150A CN201310568900.1A CN201310568900A CN103768150A CN 103768150 A CN103768150 A CN 103768150A CN 201310568900 A CN201310568900 A CN 201310568900A CN 103768150 A CN103768150 A CN 103768150A
Authority
CN
China
Prior art keywords
part composition
chinese medicinal
medicinal effective
treatment
cataract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310568900.1A
Other languages
Chinese (zh)
Inventor
张群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUANGZHOU YUNQIAO BIOLOGICAL TECHNOLOGY Co Ltd
Original Assignee
GUANGZHOU YUNQIAO BIOLOGICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUANGZHOU YUNQIAO BIOLOGICAL TECHNOLOGY Co Ltd filed Critical GUANGZHOU YUNQIAO BIOLOGICAL TECHNOLOGY Co Ltd
Priority to CN201310568900.1A priority Critical patent/CN103768150A/en
Publication of CN103768150A publication Critical patent/CN103768150A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine effective part composition for treating cataract, which adopts such raw materials in parts by weight as fructus caryophylli, ferula asafetida, fraxinus chinensis, blumea balsamifera, senecio scandens and coriolus versicolor. The traditional Chinese medicine effective part composition provided by the invention has the effects of tonifying the liver and kidney, nourishing yin, improving eyesight, invigorating spleen, supplementing qi, promoting blood circulation to remove blood stasis, removing cataract and nourishing the stomach, is effective in treatment of cataract, has no side effects, and is high in safety.

Description

One is treated cataractous Chinese medicinal effective-part composition
Technical field
The present invention relates to Chinese medicine composition field, be specifically related to one and be used for the treatment of cataractous Chinese medicinal effective-part composition.
Background technology
Cataract, is a kind of oculopathy affecting one's power of vision because crystalline lens is muddy, is more common in old people, is also a kind of common complication of diabetes.In addition, touching some harmful substance, injure the generation that congenital factor also can cause primary disease outward, is the one of the main reasons of current mankind's blinding.
Summary of the invention
The object of the present invention is to provide one for the preparation of the cataractous Chinese medicinal effective-part composition for the treatment of, this active component composition can be treated cataract, and is difficult for recurrence.
Above-mentioned purpose of the present invention is achieved by the following technical programs:
At present, the traditional Chinese medical science thinks that cataract is caused by worn with age, the reason such as natural endowment is not enough, wound or violence, and its pathogenesis is mainly the hepatic and renal YIN deficiency and deficiency of spleen-QI and stomach-QI and the stasis of blood.
One is treated cataractous Chinese medicinal effective-part composition, by making according to the raw material of mass fraction meter as follows: Fructus Caryophylli 24, Resina Ferulae 22, Chinese ash 21, Herba Blumeae Balsamiferae 17, Herba Senecionis Scandentis 14 and Coriolous Dersicolor (Fr.) Quel 2.
The preparation method of Chinese medicinal effective-part composition of the present invention be by above-mentioned raw materials compositions according to proportioning combination drying, add 16 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
Compared with prior art, the present invention has following beneficial effect:
Find through experiment, the Chinese medicinal effective-part composition of making according to proportioning of the present invention has liver and kidney tonifying, YIN nourishing improving eyesight, invigorating the spleen and benefiting QI, blood circulation promoting and blood stasis dispelling, the effect of barrier nourishing the stomach of dispelling, and can be used for the treatment of cataract, after curing, is difficult for recurrence.
The specific embodiment
Further explain the present invention below in conjunction with embodiment, but embodiment does not limit in any form to the present invention.
embodiment 1
Fructus Caryophylli 24g, Resina Ferulae 22g, Chinese ash 21g, Herba Blumeae Balsamiferae 17g, Herba Senecionis Scandentis 14g and Coriolous Dersicolor (Fr.) Quel 2g, add 16 times of water gagings after being dried, and after boiling, then uses slow fire decocting 180min with intense fire, and gained decoction is for subsequent use.
embodiment 2
500 of clinical observation cataract patients.Patient is all diagnosed as cataract through clinical diagnosis.Take embodiment 1 gained decoction to patient, 2 times on the 1st, sooner or later bfore meals, continuous 15 days.
Take patient's statistical result of embodiment 1 gained decoction in table 1.Wherein effectively comprise recovery from illness and effectively, recovery from illness refers to through treatment, check with international standard visual acuity chart, vision improve 3 row or more than; Effectively refer to that, through treatment, vision improves 1 ~ 2 row.Invalid refer to through treatment, vision unchanged or decline.
Table 1
Number of cases Effective Invalid Obvious effective rate (%)
500 487 13 97.4
Known by above-mentioned data, Chinese medicine of the present invention is made after decoction, can be in 15 days the treatment cataract of highly significant.
embodiment 3
The decoction administration ICR mice that uses embodiment 1 to make, body weight 20 ~ 25g, male and female half and half, successive administration 60d.
Through prerun, the decoction toxicity that embodiment 1 makes is very low, does not measure LD50, measures therefore mice is carried out to maximum dosage-feeding on the one.Maximum dosage-feeding is 400ml/d, observes none example and be poisoned to death after 60 days, and all healthy survival, proves that the decoction that compositions of the present invention is made can toxic side effect to human body thus.

Claims (4)

1. the cataractous Chinese medicinal effective-part composition for the treatment of, is characterized in that by making according to the raw material of mass fraction meter as follows: Fructus Caryophylli 24, Resina Ferulae 22, Chinese ash 21, Herba Blumeae Balsamiferae 17, Herba Senecionis Scandentis 14 and Coriolous Dersicolor (Fr.) Quel 2.
2. the cataractous Chinese medicinal effective-part composition for the treatment of according to claim 1, is characterized in that described Chinese medicinal effective-part composition makes decoction.
3. described in claim 1 or 2, treat the preparation method of cataractous Chinese medicinal effective-part composition, it is characterized in that each crude drug, according to proportioning combination drying, adding 16 times of water gagings, boil with high heat, change slow fire boiling into 3 hours, waste, to obtain final product.
4. the application of Chinese medicinal effective-part composition described in claim 1 or 2, is characterized in that described Chinese medicinal effective-part composition is for the preparation of the cataractous medicine for the treatment of.
CN201310568900.1A 2013-11-15 2013-11-15 Traditional Chinese medicine effective part composition for treating cataract Pending CN103768150A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310568900.1A CN103768150A (en) 2013-11-15 2013-11-15 Traditional Chinese medicine effective part composition for treating cataract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310568900.1A CN103768150A (en) 2013-11-15 2013-11-15 Traditional Chinese medicine effective part composition for treating cataract

Publications (1)

Publication Number Publication Date
CN103768150A true CN103768150A (en) 2014-05-07

Family

ID=50561210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310568900.1A Pending CN103768150A (en) 2013-11-15 2013-11-15 Traditional Chinese medicine effective part composition for treating cataract

Country Status (1)

Country Link
CN (1) CN103768150A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10195591B2 (en) 2017-04-24 2019-02-05 Suzhou Toreto New Material Ltd. Binder-free high strength, low steam-to-oil ratio ethylbenzene dehydrogenation catalyst

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH045237A (en) * 1990-04-24 1992-01-09 Nonogawa Shoji Kk Superoxide eliminant
US20090004334A1 (en) * 2007-06-29 2009-01-01 Vijaya Nair Dietary nutritional supplements for heal thcare
CN103341020A (en) * 2013-07-29 2013-10-09 阚景平 Traditional Chinese medicine preparation for treating radiation cataract and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH045237A (en) * 1990-04-24 1992-01-09 Nonogawa Shoji Kk Superoxide eliminant
US20090004334A1 (en) * 2007-06-29 2009-01-01 Vijaya Nair Dietary nutritional supplements for heal thcare
CN103341020A (en) * 2013-07-29 2013-10-09 阚景平 Traditional Chinese medicine preparation for treating radiation cataract and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
吴名波: "中药防治糖性白内障的作用机制研究进展", 《眼科新进展》, vol. 28, no. 4, 30 April 2008 (2008-04-30), pages 316 - 317 *
李仕兴: "秦艽花椒散治疗耕牛内障眼", 《中国兽医科技》, vol. 25, no. 5, 31 December 1995 (1995-12-31), pages 11 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10195591B2 (en) 2017-04-24 2019-02-05 Suzhou Toreto New Material Ltd. Binder-free high strength, low steam-to-oil ratio ethylbenzene dehydrogenation catalyst
US10406508B2 (en) 2017-04-24 2019-09-10 Suzhou Toreto New Material Ltd. Binder-free high strength, low steam-to-oil ratio ethylbenzene dehydrogenation catalyst

Similar Documents

Publication Publication Date Title
CN103463539B (en) A kind of medicine for the treatment of eczema and its production and use
CN102319288B (en) Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof
CN103768150A (en) Traditional Chinese medicine effective part composition for treating cataract
CN103861007B (en) A kind of Chinese herbal compound preparation for the treatment of chicken diarrhea
CN103585580B (en) A kind of Chinese medicine preparation for recurrent oral ulceration
CN102670863B (en) Compound propolis composition for treating acariasis of domestic animal and preparation method thereof
CN101732425B (en) Externally-applied medicine composite for psoriasis
CN104474405A (en) Traditional Chinese medicine composition for treating chloasma
CN103432333B (en) Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism
CN103768341A (en) Traditional Chinese medicine effective part composition for treating primary glaucoma
CN103550744B (en) A kind of pure Chinese medicinal preparation for oral ulcer
CN106822271A (en) It is a kind of to treat pharmaceutical composition of rheumatic Bi syndrome and its production and use
CN103432204B (en) Traditional Chinese medicine effective part composition for treating schizophrenia and preparation method thereof
CN105853556A (en) Medicine for treating fungal, viral and bacterial skin disease and sexual skin disease
CN102961487B (en) Compound combination made from pure traditional Chinese medicines and used for treating henpox and preparation method of combination
CN105687385A (en) Ointment for treating radiodermatitis and preparation
CN102228661B (en) Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis
CN103768194A (en) Traditional Chinese medicine effective part composition for treating rheumatic heart disease
CN105381177A (en) External use traditional Chinese medicine for treating sweet stains
CN103585534A (en) Traditional Chinese medicine effective part composition for treating erythema multiforme
CN103768312A (en) Traditional Chinese medicine effective part composition for treating Meniere's disease
CN104491215B (en) A kind of Chinese medicine for treating flaccid paralysis
CN104001031A (en) Medicament for treating asthma
CN104398596A (en) Traditional Chinese medicinal formula for treating oral ulcer
CN104435979B (en) A kind of medicine for treating rheumatic lumbocrural pain pain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140507